Myeloid-specific deletion of tumor suppressor PTEN augments neutrophil transendothelial migration during inflammation

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7190-7200

  Sarraj, Bara ^a   Massberg, Steffen ^b   Li, Yitang ^a   Kasorn, Anongnard ^a   Subramanian, Kulandayan ^a   Loison, Fabien ^a   Silberstein, Leslie E ^a,b   Von Andrian, Ulrich ^a   Luo, Hongbo R ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GELATINASE; MACROPHAGE INFLAMMATORY PROTEIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; CXCL2 CHEMOKINE; PTEN PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; ENZYME RELEASE; GENE DELETION; IN VIVO STUDY; INFLAMMATION; INTRAVITAL VIDEO MICROSCOPY; ISCHEMIA; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MICROSCOPY; MOUSE; MUSCLE TISSUE; NEUROPHYSIOLOGICAL RECRUITMENT; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VENULE; WILD TYPE; ANIMAL; BONE MARROW CELL; ENDOTHELIUM; IMMUNOLOGY; LEUKOCYTE ROLLING; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; CHEMOKINE CXCL2; ENDOTHELIUM; INFLAMMATION; LEUKOCYTE ROLLING; MICE; MICE, KNOCKOUT; MICROSCOPY, VIDEO; MUSCLE, SKELETAL; MYELOID CELLS; NEUTROPHIL INFILTRATION; PTEN PHOSPHOHYDROLASE; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 67449138541     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802562     Document Type: Article

References (78)

1. Bokoch, G. M. 1995. Chemoattractant signaling and leukocyte activation. Blood 86: 1649-1660.
2. Devreotes, P. N., and S. H. Zigmond. 1988. Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu. Rev. Cell Biol. 4: 649-686.
3. Olson, T. S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. 283: R7-R28.
4. Katso, R., K. Okkenhaug, K. Ahmadi, S. White, J. Timms, and M. D. Waterfield. 2001. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17: 615-675.
5. Stephens, L., C. Ellson, and P. Hawkins. 2002. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr. Opin. Cell Biol. 14: 203-213.
6. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302: 1704-1709.
7. Bourne, H. R., and O. Weiner. 2002. A chemical compass. Nature 419: 21.
8. Shaw, G. 1996. The pleckstrin homology domain: an intriguing multifunctional protein module. Bioessays 18: 35-46. (Pubitemid 3023116)
9. Lemmon, M. A. 2003. Phosphoinositide recognition domains. Traffic 4: 201-213.
10. Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
11. Rickert, P., O. D. Weiner, F. Wang, H. R. Bourne, and G. Servant. 2000. Leukocytes navigate by compass: roles of PI3Kγ and its lipid products. Trends Cell Biol. 10: 466-473.
12. Corvera, S., and M. P. Czech. 1998. Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol. 8: 442-446.
13. Parent, C. A., B. J. Blacklock, W. M. Froehlich, D. B. Murphy, and P. N. Devreotes. 1998. G protein signaling events are activated at the leading edge of chemotactic cells. Cell 95: 81-91.
14. Liliental, J., S. Y. Moon, R. Lesche, R. Mamillapalli, D. Li, Y. Zheng, H. Sun, and H. Wu. 2000. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10: 401-404.
15. Camps, M., T. Ruckle, H. Ji, V. Ardissone, F. Rintelen, J. Shaw, C. Ferrandi, C. Chabert, C. Gillieron, B. Francon, et al. 2005. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11: 936-943.
16. Smith, D. F., T. L. Deem, A. C. Bruce, J. Reutershan, D. Wu, and K. Ley. 2006. Leukocyte phosphoinositide-3 kinase γ is required for chemokine-induced, sustained adhesion under flow in vivo. J. Leukocyte Biol. 80: 1491-1499.
17. Liu, L., K. D. Puri, J. M. Penninger, and P. Kubes. 2007. Leukocyte PI3Kγ and PI3Kδ have temporally distinct roles for leukocyte recruitment in vivo. Blood 110: 1191-1198.
18. Puri, K. D., T. A. Doggett, J. Douangpanya, Y. Hou, W. T. Tino, T. Wilson, T. Graf, E. Clayton, M. Turner, J. S. Hayflick, and T. G. Diacovo. 2004. Mechanisms and implications of phosphoinositide 3-kinase δ in promoting neutrophil trafficking into inflamed tissue. Blood 103: 3448-3456.
19. Puri, K. D., T. A. Doggett, C. Y. Huang, J. Douangpanya, J. S. Hayflick, M. Turner, J. Penninger, and T. G. Diacovo. 2005. The role of endothelial PI3Kγ activity in neutrophil trafficking. Blood 106: 150-157.
20. Heit, B., L. Liu, P. Colarusso, K. D. Puri, and P. Kubes. 2008. PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. J. Cell Sci. 121: 205-214.
21. Sasaki, T., J. Irie-Sasaki, R. G. Jones, A. J. Oliveira-dos-Santos, W. L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, et al. 2000. Function of PI3Kγ in thymocyte development: T cell activation, and neutrophil migration. Science 287: 1040-1046.
22. Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda, and M. P. Wymann. 2000. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287: 1049-1053.
23. Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
24. Steck, P. A., M. A. Pershouse, S. A. Jasser, W. K. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, et al. 1997. Identification of a candidate tumour suppressor gene: MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15: 356-362.
25. Maehama, T., and J. E. Dixon. 1999. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9: 125-128.
26. Gao, P., R. L. Wange, N. Zhang, J. J. Oppenheim, and O. M. Howard. 2005. Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN. Blood 106: 2619-2626.
27. Kwak, Y. G., C. H. Song, H. K. Yi, P. H. Hwang, J. S. Kim, K. S. Lee, and Y. C. Lee. 2003. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111: 1083-1092.
28. Lacalle, R. A., C. Gomez-Mouton, D. F. Barber, S. Jimenez-Baranda, E. Mira, A. C. Martinez, A. C. Carrera, and S. Manes. 2004. PTEN regulates motility but not directionality during leukocyte chemotaxis. J. Cell Sci. 117: 6207-6215.
29. Tamura, M., J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K. M. Yamada. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617.
30. Subramanian, K. K., Y. Jia, D. Zhu, B. T. Simms, H. Jo, H. Hattori, J. You, J. P. Mizgerd, and H. R. Luo. 2007. Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood 109: 4028-4037.
31. Muller, W. A. 2003. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24: 327-334.
32. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
33. Foxman, E. F., J. J. Campbell, and E. C. Butcher. 1997. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139: 1349-1360.
34. Wagner, J. G., and R. A. Roth. 2000. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 52: 349-374.
35. Simon, S. I., and C. E. Green. 2005. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu. Rev. Biomed. Eng. 7: 151-185.
36. von Andrian, U. H., and K. E. Arfors. 1993. Neutrophil-endothelial cell interactions in vivo: a chain of events characterized by distinct molecular mechanisms. Agents Actions Suppl. 41: 153-164.
37. Luster, A. D., R. Alon, and U. H. von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6: 1182-1190.
38. von Andrian, U. H., J. D. Chambers, L. M. McEvoy, R. F. Bargatze, K. E. Arfors, and E. C. Butcher. 1991. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc. Natl. Acad. Sci. USA 88: 7538-7542.
39. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57: 827-872.
40. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689.
41. Zhu, D., H. Hattori, H. Jo, Y. Jia, K. K. Subramanian, F. Loison, J. You, Y. Le, M. Honczarenko, L. Silberstein, and H. R. Luo. 2006. Deactivation of phosphatidylinositol 3,4,5-trisphosphate/Akt signaling mediates neutrophil spontaneous death. Proc. Natl. Acad. Sci. USA 103: 14836-14841.
42. Weninger, W., H. S. Carlsen, M. Goodarzi, F. Moazed, M. A. Crowley, E. S. Baekkevold, L. L. Cavanagh, and U. H. von Andrian. 2003. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J. Immunol. 170: 4638-4648. (Pubitemid 36519970)
43. Coxon, A., P. Rieu, F. J. Barkalow, S. Askari, A. H. Sharpe, U. H. von Andrian, M. A. Arnaout, and T. N. Mayadas. 1996. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5: 653-666.
44. Ley, K., D. C. Bullard, M. L. Arbones, R. Bosse, D. Vestweber, T. F. Tedder, and A. L. Beaudet. 1995. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 181: 669-675.
45. Khadaroo, R. G., R. He, J. Parodo, K. A. Powers, J. C. Marshall, A. Kapus, and O. D. Rotstein. 2004. The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo. Surgery 136: 483-488.
46. Kanwar, S., M. J. Hickey, and P. Kubes. 1998. Postischemic inflammation: a role for mast cells in intestine but not in skeletal muscle. Am. J. Physiol. 275: G212-G218.
47. Woodfin, A., C. A. Reichel, A. Khandoga, M. Corada, M. B. Voisin, C. Scheiermann, D. O. Haskard, E. Dejana, F. Krombach, and S. Nourshargh. 2007. JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 110: 1848-1856.
48. Smith, M. L., M. J. Smith, M. B. Lawrence, and K. Ley. 2002. Viscosity-independent velocity of neutrophils rolling on P-selectin in vitro or in vivo. Microcirculation 9: 523-536.
49. Forlow, S. B., and K. Ley. 2001. Selectin-independent leukocyte rolling and adhesion in mice deficient in E-, P-, and L-selectin and ICAM-1. Am. J. Physiol. 280: H634-H641.
50. Liu, L., D. C. Cara, J. Kaur, E. Raharjo, S. C. Mullaly, J. Jongstra-Bilen, J. Jongstra, and P. Kubes. 2005. LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J. Exp. Med. 201: 409-418.
51. Phillipson, M., B. Heit, P. Colarusso, L. Liu, C. M. Ballantyne, and P. Kubes. 2006. Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J. Exp. Med. 203: 2569-2575.
52. Zhang, X. W., Y. Wang, Q. Liu, and H. Thorlacius. 2001. Redundant function of macrophage inflammatory protein-2 and KC in tumor necrosis factor-α-induced extravasation of neutrophils in vivo. Eur. J. Pharmacol. 427: 277-283.
53. Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670.
54. Schenkel, A. R., Z. Mamdouh, and W. A. Muller. 2004. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat. Immunol. 5: 393-400.
55. Vestweber, D. 2007. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 218: 178-196.
56. Nourshargh, S., and F. M. Marelli-Berg. 2005. Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol. 26: 157-165.
57. Feng, D., J. A. Nagy, K. Pyne, H. F. Dvorak, and A. M. Dvorak. 2004. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem. Cytochem. 52: 87-101. (Pubitemid 38032136)
58. Seal, J. B., and B. L. Gewertz. 2005. Vascular dysfunction in ischemia-reperfusion injury. Ann. Vasc. Surg. 19: 572-584.
59. Petri, B., M. Phillipson, and P. Kubes. 2008. The physiology of leukocyte recruitment: an in vivo perspective. J. Immunol. 180: 6439-6446.
60. Weber, C., L. Fraemohs, and E. Dejana. 2007. The role of junctional adhesion molecules in vascular inflammation. Nat. Rev. Immunol. 7: 467-477.
61. Wang, S., J. P. Dangerfield, R. E. Young, and S. Nourshargh. 2005. PECAM-1, alpha6 integrins and neutrophil elastase cooperate in mediating neutrophil transmigration. J. Cell Sci. 118: 2067-2076.
62. Allport, J. R., H. Ding, T. Collins, M. E. Gerritsen, and F. W. Luscinskas. 1997. Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J. Exp. Med. 186: 517-527.
63. Moll, T., E. Dejana, and D. Vestweber. 1998. In vitro degradation of endothelial catenins by a neutrophil protease. J. Cell Biol. 140: 403-407.
64. Reichel, C. A., M. Rehberg, P. Bihari, C. M. Moser, S. Linder, A. Khandoga, and F. Krombach. 2008. Gelatinases mediate neutrophil recruitment in vivo: evidence for stimulus specificity and a critical role in collagen IV remodeling. J. Leukocyte Biol. 83: 864-874.
65. Ducharme, A., S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, L. E. Rohde, F. J. Schoen, R. A. Kelly, Z. Werb, P. Libby, and R. T. Lee. 2000. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106: 55-62.
66. Renckens, R., J. J. Roelofs, S. Florquin, A. F. de Vos, H. R. Lijnen, C. van't Veer, and T. van der Poll. 2006. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J. Immunol. 176: 3735-3741.
67. Heit, B., S. M. Robbins, C. M. Downey, Z. Guan, P. Colarusso, B. J. Miller, F. R. Jirik, and P. Kubes. 2008. PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat. Immunol. 9: 743-752.
68. Wojciechowski, J. C., and I. H. Sarelius. 2005. Preferential binding of leukocytes to the endothelial junction region in venules in situ. Microcirculation 12: 349-359.
69. Carman, C. V., P. T. Sage, T. E. Sciuto, M. A. de la Fuente, R. S. Geha, H. D. Ochs, H. F. Dvorak, A. M. Dvorak, and T. A. Springer. 2007. Transcellular diapedesis is initiated by invasive podosomes. Immunity 26: 784-797.
70. Li, Z., X. Dong, Z. Wang, W. Liu, N. Deng, Y. Ding, L. Tang, T. Hla, R. Zeng, L. Li, and D. Wu. 2005. Regulation of PTEN by Rho small GTPases. Nat. Cell Biol. 7: 399-404.
71. Iijima, M., and P. Devreotes. 2002. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 109: 599-610.
72. Simon, S. I., Y. Hu, D. Vestweber, and C. W. Smith. 2000. Neutrophil tethering on E-selectin activates β2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J. Immunol. 164: 4348-4358.
73. Hidalgo, A., A. J. Peired, M. K. Wild, D. Vestweber, and P. S. Frenette. 2007. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26: 477-489.
74. 2 integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 26: 773-783.
75. Miner, J. J., L. Xia, T. Yago, J. Kappelmayer, Z. Liu, A. G. Klopocki, B. Shao, J. M. McDaniel, H. Setiadi, D. W. Schmidtke, and R. P. McEver. 2008. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 112: 2035-2045.
76. Hidari, K. I., A. S. Weyrich, G. A. Zimmerman, and R. P. McEver. 1997. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J. Biol. Chem. 272: 28750-28756.
77. Waddell, T. K., L. Fialkow, C. K. Chan, T. K. Kishimoto, and G. P. Downey. 1995. Signaling functions of L-selectin: enhancement of tyrosine phosphorylation and activation of MAP kinase. J. Biol. Chem. 270: 15403-15411.
78. Zarbock, A., C. L. Abram, M. Hundt, A. Altman, C. A. Lowell, and K. Ley. 2008. PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcRγ to induce slow leukocyte rolling. J. Exp. Med. 205: 2339-2347.